Quality control
Malaria is one of the biggest killers in the developing world. In order to wage war on this disease the quality of the drugs that are available must be of the highest possible.
Malaria is one of the biggest killers in the developing world. In order to wage war on this disease the quality of the drugs that are available must be of the highest possible. However, quality control of drugs in formulations is still a major challenge in developing countries. A team of scientists has therefore conducted an experiment using capillary electrophoresis to perform quality control on commercial fixed-dose combination tablets.1
The team used a micellar electrokinetic capillary chromatography method (MEKC) to determine artesunate and amodiaquine hydrochloride. Analytes were extracted from tablets by sonication with a solvent mixture phosphate buffer pH 7.0 acetonitrile containing benzoic acid as internal standard.
Artesunate, amodiquine and benzoic acid were separated in 6 min. The method was found to be reliable in terms of specificity, linearity of the calibration line, recovery from synthetic tablets and repeatability.
However, the main benefit of the method was the low cost of the capillary itself, its long lifetime and the low consumption of separation electrolyte. The team concluded that the method is very well-suited for drug quality control and the detection of counterfeit or substandard medicines.
1. Fabre et al., Malaria Journal11(149) doi:10.1186/1475-2875-11-149 (2012).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
